Humulin R
Humulin R is a short-acting human insulin. It works by bringing glucose into cells so your body can use it for energy, thereby lowering blood sugar levels. It typically begins working within 30 minutes, reaches its peak effect at 2 to 3 hours, and lasts for approximately 5 to 8 hours.
Dosage by Body Weight
Dosage must be highly individualized and determined by a healthcare professional based on blood glucose monitoring, metabolic needs, eating habits, and physical activity levels. Administer subcutaneously approximately 30 minutes before a meal.
- Body Weight
- Below 5 kg
- Dose
- Highly individualized
- Frequency
- As directed by physician
- Tracking Notes
- Extremely high risk of hypoglycemia. Use only under strict pediatric endocrinologist supervision. Dose is often less than 0.5 units.
- Body Weight
- 5-7 kg
- Dose
- 0.5 units (approximate starting guidance)
- Frequency
- Typically 30 minutes before meals
- Tracking Notes
- Monitor blood glucose levels immediately before injection. Dose must be adjusted based on carbohydrate intake.
- Body Weight
- 8-10 kg
- Dose
- 0.5 to 1 unit (approximate starting guidance)
- Frequency
- Typically 30 minutes before meals
- Tracking Notes
- Monitor blood glucose levels. Adjust according to individualized insulin-to-carbohydrate ratio.
- Body Weight
- 11-15 kg
- Dose
- 1 to 1.5 units (approximate starting guidance)
- Frequency
- Typically 30 minutes before meals
- Tracking Notes
- Dose must be individualized. High risk of hypoglycemia if meal is skipped or delayed.
- Body Weight
- 16-20 kg
- Dose
- 1.5 to 2 units (approximate starting guidance)
- Frequency
- Typically 30 minutes before meals
- Tracking Notes
- Dose adjusted dynamically based on sliding scale, carbohydrate counting, and physical activity.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Highly individualized | As directed by physician | Extremely high risk of hypoglycemia. Use only under strict pediatric endocrinologist supervision. Dose is often less than 0.5 units. |
| 5-7 kg | 0.5 units (approximate starting guidance) | Typically 30 minutes before meals | Monitor blood glucose levels immediately before injection. Dose must be adjusted based on carbohydrate intake. |
| 8-10 kg | 0.5 to 1 unit (approximate starting guidance) | Typically 30 minutes before meals | Monitor blood glucose levels. Adjust according to individualized insulin-to-carbohydrate ratio. |
| 11-15 kg | 1 to 1.5 units (approximate starting guidance) | Typically 30 minutes before meals | Dose must be individualized. High risk of hypoglycemia if meal is skipped or delayed. |
| 16-20 kg | 1.5 to 2 units (approximate starting guidance) | Typically 30 minutes before meals | Dose adjusted dynamically based on sliding scale, carbohydrate counting, and physical activity. |
Formulation
Injection vialInjection pen (KwikPen)
Purpose
To improve glycemic control in adults and pediatric patients with type 1 and type 2 diabetes mellitus.
Generic Name
Insulin Regular (Human Recombinant)Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.